Congratulations to portfolio company RefleXion Medical on receiving FDA clearance of its SCINTIX™ biology-guided radiotherapy! SCINTIX technology is a novel therapy for patients with tumors in the lung or bone arising from primary or metastatic disease. Read the press release to learn how, for the first time ever, the cancer itself directs treatment via a live stream of PET emissions data that continuously communicates with the linear accelerator.